Intracranial hypertension induced by rofecoxib

Headache

Volumn 45, Issue 1, 2005, Pages 75-76

  Jacob, Saiju ^a   Rajabally, Yusuf A ^a  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

Author keywords

Intracranial hypertension; Rofecoxib

Indexed keywords

ANTIHYPERTENSIVE AGENT; ROFECOXIB;

AGED; ANAMNESIS; ARTICLE; BRAIN ISCHEMIA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIPLOPIA; DRUG WITHDRAWAL; HEADACHE; HUMAN; HYPERTENSION; INTRACRANIAL HYPERTENSION; LABORATORY TEST; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SINUS VENOSUS;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; CYCLOOXYGENASE INHIBITORS; HUMANS; INTRACRANIAL HYPERTENSION; LACTONES; MALE; SULFONES;

EID: 11844253137     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2005.05013.x     Document Type: Article

References (7)

1. Smith JL. Whence pseudotumor cerebri? J Clin Neuroophthalmol. 1985;5:55-56.
2. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002;59:1492-1495.
3. Digre KB, Corbett JJ. Idiopathic intracranial hypertension (pseudotumor cerebri): a reappraisal. Neurologist. 2001;7:2-67.
4. Scott LJ, Lamb HM. Rofecoxib. Drugs. 1999;58:499-505.
5. Brinker A, Goldkind L, Bonnel R, Beitz J. Spontaneous reports of hypertension leading to hospitalisation in association with rofecoxib, celecoxib, nabumetone and oxaprozin. Drugs Aging. 2004;21:479-484.
6. Cho J, Cooke CE, Proveaux W. A retrospective review of the effect of COX-2 inhibitors on blood pressure change. Am J Ther. 2003;10:311-317.
7. Wolfe F, Zhao S, Pettitt D. Blood pressure destabilisation and edema among 8538 users of celecoxib, rofecoxib and nonselective nonsteroidal anti-inflammatory drugs (NSAID) and nonusers of NSAID receiving ordinary clinical care. J Rheumatol. 2004;31:1143-1151.